KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Cash & Current Investments (2018 - 2025)

Progyny (PGNY) has disclosed Cash & Current Investments for 8 consecutive years, with $310.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments changed N/A to $310.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $310.1 million, a N/A change, with the full-year FY2025 number at $310.1 million, changed N/A from a year prior.
  • Cash & Current Investments was $310.1 million for Q4 2025 at Progyny, down from $345.2 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $371.8 million in Q1 2024 to a low of $94.0 million in Q2 2021.
  • A 5-year average of $225.1 million and a median of $235.7 million in 2024 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 137.99% in 2023, then plummeted 31.12% in 2025.
  • Progyny's Cash & Current Investments stood at $119.4 million in 2021, then soared by 58.52% to $189.3 million in 2022, then surged by 96.03% to $371.1 million in 2023, then crashed by 36.48% to $235.7 million in 2024, then surged by 31.55% to $310.1 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Cash & Current Investments are $310.1 million (Q4 2025), $345.2 million (Q3 2025), and $305.1 million (Q2 2025).